Antibiotic · Drug monograph
Cefixime: veterinary dose and monograph
Cefixime is a veterinary antibiotic. An ORAL third-generation cephalosporin — a convenient oral option for Gram-negative infections (notably resistant UTIs, soft-tissue and some respiratory infections) when an injectable third-generation drug is not needed. Indications include resistant / complicated urinary tract infection (oral); susceptible Gram-negative soft-tissue and respiratory infections; step-down oral therapy after parenteral cephalosporins. This monograph lists 2 reference doses for dogs and cats, each with route, frequency and source.
At a glance
- Drug class
- Antibiotic
- Also known as
- Taxim-O, Zifi, Cefolac, Suprax
- Species with doses
- Dogs and Cats
- General dose range
- 5–12.5 mg/kg PO q12–24h — check the species tables for the indication
- Routes
- PO
- Last reviewed
- 1 October 2026
Indications
- Resistant / complicated urinary tract infection (oral)
- Susceptible Gram-negative soft-tissue and respiratory infections
- Step-down oral therapy after parenteral cephalosporins
- Gram-negative infections where oral dosing is preferred
Cefixime dose by species
Doses are per administration unless stated. mg/kg doses scale with body weight; per-animal, per-quarter and infusion-rate doses are shown as the reference writes them.
Dogs
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Susceptible Gram-negative / UTI | 5–12.5 mg/kg | PO | q12–24h | — |
- Susceptible Gram-negative / UTI: Papich 5e: 10 mg/kg q12h PO; UTI 5 mg/kg q12–24h. Plumb’s p.214: UTI 5 mg/kg once or twice daily for 7–14 days; respiratory/systemic 12.5 mg/kg q12h (Greene); endocarditis 10 mg/kg q12h (DeFrancesco).
Cats
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Susceptible Gram-negative infection | 5–12.5 mg/kg | PO | q12h | — |
- Susceptible Gram-negative infection: Papich 5e: dogs and cats 10 mg/kg q12h PO; UTI 5 mg/kg q12–24h. Plumb’s p.214 (Lappin 2002): cats 5–12.5 mg/kg PO q12h.
Contraindications
Beta-lactam (penicillin/cephalosporin) hypersensitivity. Reduce dose in significant renal impairment. Not ideal for staphylococcal pyoderma (weak Gram-positive cover). Routine first-line empiric use (stewardship). Known hypersensitivity.
Adverse effects
- GI upset (vomiting, diarrhoea) — give with food
- Hypersensitivity reactions
- Antibiotic-associated diarrhoea / dysbiosis
- Rare: raised liver enzymes
Drug interactions
- Aminoglycosides: additive nephrotoxicity (and synergy vs some Gram-negatives)
- Probenecid: prolongs half-life
- Bacteriostatic agents: possible antagonism
- Antacids/H2-blockers: minor reduction in absorption
Pregnancy and lactation
Cephalosporins are generally considered safe in pregnancy/lactation.
Monitoring
- Culture & sensitivity (confirm a susceptible Gram-negative) and clinical response
- GI tolerance
- Renal function in renal patients
Toxicity and overdose
Wide margin — acute toxicity essentially limited to GI upset and hypersensitivity. Accumulates in renal impairment. Overuse drives third-generation cephalosporin (ESBL) resistance — the main ecological concern.
Management: Supportive; no specific antidote. Treat hypersensitivity conventionally; fluids and dose reduction in renal impairment.
Clinical pearls
- A handy ORAL third-generation cephalosporin for resistant Gram-negative UTIs — but weak against Staph, so not for pyoderma
- Useful step-down from injectable cephalosporins to finish a course orally
- Cheap and ubiquitous in India (Taxim-O/Zifi) — reserve it (culture-driven) to slow ESBL resistance
- Give with food to reduce GI upset; reduce dose in renal impairment
Mechanism of action
Beta-lactam that binds penicillin-binding proteins to inhibit bacterial cell-wall peptidoglycan cross-linking — bactericidal, time-dependent. As an oral third-generation cephalosporin it is stable against many Gram-negative beta-lactamases and penetrates the Gram-negative outer membrane well, giving strong Gram-negative activity with comparatively limited Gram-positive (especially staphylococcal) reach.
Formulations and products
- 50 mg tablet/DT
- 100 / 200 mg tablet
- Oral suspension 20 mg/mL (100 mg/5 mL)
- Taxim-O — 50 / 100 / 200 mg tablet; 100 mg/5 mL suspension, Tablet / suspension (human-label)
- Zifi — 50 / 100 / 200 mg tablet; suspension, Tablet / suspension (human-label)
Storage
Tablets: 15–30 °C, dry. Reconstituted suspension: per label (often refrigerated; discard after ~10–14 days), shake well.
Before you use this dose
Reference doses for veterinary professionals. Confirm the dose against the product label, the patient’s condition, current guidance and local regulations before use; the attending veterinarian remains responsible for every clinical decision.
Frequently asked questions
What is the dose of Cefixime for dogs?
Reference doses for Cefixime in dogs: 5–12.5 mg/kg PO q12–24h (Susceptible Gram-negative / UTI). Confirm against the label and the patient before use.
What is the dose of Cefixime for cats?
Reference doses for Cefixime in cats: 5–12.5 mg/kg PO q12h (Susceptible Gram-negative infection). Confirm against the label and the patient before use.
When should Cefixime not be used?
Beta-lactam (penicillin/cephalosporin) hypersensitivity. Reduce dose in significant renal impairment. Not ideal for staphylococcal pyoderma (weak Gram-positive cover). Routine first-line empiric use (stewardship). Known hypersensitivity.
What are the side effects of Cefixime in animals?
GI upset (vomiting, diarrhoea) — give with food; Hypersensitivity reactions; Antibiotic-associated diarrhoea / dysbiosis; Rare: raised liver enzymes.
Sources
- Plumb's Veterinary Drug Handbook
- Merck Veterinary Manual, 11th edition
- Papich, Papich Handbook of Veterinary Drugs, 5th edition
Last reviewed · VetMasterJi